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OBJECTIVES: To illustrate the relationships among sensitivity/specificity, disease
prevalence and PPV/NPV, and demonstrate the impact on model results when
disease prevalence is not considered. METHODS: Using the literature on the sen-
sitivity and specificity of single-photon emission computed tomography (SPECT)
and positron emission tomography (PET) for detecting coronary artery disease as
an example, we derive the PPV/NPV taking prevalence into account. Then we de-
rive the rate of FN and FP from the reported mean sensitivity/specificity as well as
from the varying PPV/NPV. RESULTS:Mean sensitivity and specificity for PET were
0.9 and 0.83, with associated FN and FP of0.1 and 0.17. When using PPV/NPV to
derive FN and FP, FN ranged from 0.05 to 0.22 when prevalence varied from 0.3 to
0.7, while FP ranged from 0.31 to 0.07. Sensitivity and specificity for SPECT were
reported as 0.85 and 0.72,with associated FNand FP of 0.15 and 0.28. Using PPV/NPV
and a prevalence range from 0.3 to 0.7, FN varied from 0.08 to 0.33 and FP varied
from 0.43 to 0.12. CONCLUSIONS: Models results can be significantly biased if
prevalence is not taken into accountwhen deriving FN and FP for economicmodels
of diagnostic accuracy.
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SELECTING A SECONDARY DATA SOURCE FOR A LOW-VOLUME PROCEDURE IN
A SPECIALTY POPULATION: A STUDY USING INPATIENT PEDIATRIC
COLONOSCOPY
Anastassopoulos KP, Knight TG, Baik R
Covance Market Access Services, Inc., Gaithersburg, MD, USA
OBJECTIVES:The objective of this studywas to compare estimates fromsurvey and
claims data sources for a low-volume procedure within a specialty population
(specifically, the annual number of inpatient colonoscopies performed in the
United States (US) pediatric population with private insurance) to better under-
stand the considerationswhen choosing a data source.METHODS:A retrospective
analysis of US health insurance claims and national survey data was performed
using Thomson Reuters MarketScan® Commercial Claims and Encounters Da-
tabase (MarketScan®), the National Hospital Discharge Survey (NHDS), and the
National Healthcare Cost and Utilization Project Kids’ Inpatient Database (KID).
Estimates among the privately-insured were obtained overall and by age (0 to 17
years), using ICD-9-CM procedure code 45.23 for calendar year 2007 in Market-
Scan® and NHDS and 2006 in KID (2007 data not available). RESULTS:The overall,
annual estimate of inpatient, privately-insured pediatric colonoscopies was
similar between NHDS and MarketScan®; however, NHDS estimates were not
statistically reliable and differed dramatically from the prior year (overall esti-
mate was 5.6 times higher than 2006). The overall estimate from MarketScan®
was approximately 4.3 times higher than KID with estimates by age also higher;
2.8 times for age 1 to 4.2 times for age range 15-17. The KID database reported
that approximately 50% of colonoscopies were performed in pediatric hospitals.
CONCLUSIONS: The estimates weremarkedly different betweenMarketScan® and
KID, and were not statistically reliable in NHDS. Low representation of pediatric
hospitals that perform a large number of colonoscopies in this population possibly
led to inconsistent or underestimated projections in NHDS and KID, respectively.
Researchers should be informed about the frequency of the procedure of interest
and representativeness of the population in the data when selecting a data source.
Further research is warranted with other low-volume procedures performed in
specialty populations to substantiate these findings.
Surgery – Clinical Outcomes Studies
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FREQUENCIES, COSTS AND COMPLICATIONS OF CATHETER ABLATIONS FOR
PEDIATRIC TACHYCARDIA: RESULTS FROM A NATIONAL PEDIATRIC
INPATIENT DATABASE (YEARS 2000-2006)
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OBJECTIVES: Over the last two decades, catheter ablation (CA) has revolutionized
the treatment of pediatric tachycardia by providing a relatively safe alternative to
open-heart surgery or lifelong pharmacotherapy. Despite its high success rate,
however, CA has some risk of major complications, such as complete or second-
degree atrioventricular block, and a higher risk of minor complications, such as
hematoma. No study to date has estimated national frequencies and costs for CA
and its complications in children. The objectives were to 1) determine the fre-
quency of CA; 2) determine the extent ofmajor andminor complications associated
with CA; 3) estimate the average cost and length of stay (LOS) for children under-
going CA; and 4) predict the likelihood ofmajor complications based on patient and
hospital characteristics. METHODS: Data were obtained from the Kids’ Inpatient
Database (KID) for the years 2000, 2003, and 2006. Discharges were selected if CA
(ICD-9 code 37.34) was listed as a primary or secondary procedure. Costs were
computed using the KID cost-to-charge ratios. Logistic regression was used to pre-
dict the odds of major complications. RESULTS: In 2000, there were 1977 pediatric
CAs; in 2003, there were 2049; and, in 2006, 2254. CAs involving children 0-11
months old increased 2.8 fold between 2000 and 2006. The percentage of visits
involving CA complications ranged from 5.56% in 2000 to 7.72% in 2006. In 2006, the
mean cost and mean LOS for visits with CA were $19,425($1,022) and 2.39(0.2)
days, respectively. The odds of major complications from CA for atrial tachycardia
were twice (p0.01) that of supraventricular tachycardia. CONCLUSIONS: In 2006,
the national inpatient cost of CA and its complications totaled $43,783,950. Since
major complications are significantly more likely in young children (up to 6 years
old), caution is required as more such procedures are performed in this age group.
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OBJECTIVES: Bariatric surgery for the treatment of obesity and its underlying co-
morbid conditions is a well-tolerated and safe procedure. While a surgical ap-
proach is becoming the recommendedmethod of treatment formorbid obesity, not
all patients experience significant improvement. The objectives of this study were
to utilize the GE Centricity electronic medical records (EMR) database to perform a
retrospective cohort analysis on weight loss over time in patients with a record of
having laparoscopic gastric banding or bypass surgery to identify predictors of
weight loss following bariatric surgery. METHODS: Analyzable patient records
were drawn from the GE Centricity database from January 1990 through March
2010. To be eligible for inclusion, patients had a recorded CPT Procedure Code of
43644/43645 or 43770; 18 years of age; and a valid recorded BMI within 6 months
prior to procedure and at least one time point post surgery. Univariate and multi-
variable analyses were performed using SAS version 9.2. RESULTS: There were
some notable pre-surgery differences between bypass and band cohorts, including
age,weight, BMI, selected comorbid conditions anduse of antidepressants. Patients
with pre-op BMI values of less than 30 did not experience sustained weight loss, on
average, regardless of surgery type. Patients with pre-surgery BMI values of 30 to less
than35 faredbetterwithbanding (20%BMI loss) thanwithbypass (5%BMIgain) at 2
years post surgery. Finally, patients with pre-surgery BMI values of 35 and above had
greater success, on thewhole, with bypass surgery.CONCLUSIONS: The percent BMI
loss over time by four cohorts of pre-surgery BMI show a trend that may be useful
in predicting treatment success as defined by weight loss. This analysis of EMRs
demonstrates potential clinical benefits when evaluating laparoscopic gastric by-
pass and banding in a real world setting.
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LONG-TERM CLINICAL EFFECTIVENESS AND STABILITY OF LASIK AND
SURFACE ABLATION IN KOREA: A SYSTEMATIC REVIEW APPROACH
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OBJECTIVES: This study is aimed to provide evidence for clinical effectiveness and
stability after Laser in situ keratomilieusis(LASIK) and surface ablation surgery
(LASEK: Laser-Assisted Subepithelial Keratectomy, PRK: photorefractive keratoec-
tomy) for myopia in Korea.METHODS:We searched electronic database including
Ovid-Medline, EMBASE, the Cochrane Library and Korean domestic database such
as Kmbase, Korea Med, NDSL, Kisti, KISS, and KJO(Journal of The Korean Ophthal-
mological Society). Two independent reviewers extracted data and assessed the
quality using MINORS (Methodological index for Non-Randomized Studies). The
changes of UCVA(uncorrected visual acuity) and manifest refractive from pre-sur-
gery were estimated using the random-effect model. Cochrane-Q-statistic and I2-
statistic were used to assess heterogeneity. Subgroup analyses were performed by
length of follow-up(from 24month to 84 month)and myopia degree under-6D(di-
opter) and over-6D. RESULTS: Fifteen observational studies were included formeta
analysis and all study patientswereKorean. After LASIK surgery, compare to before
surgery, UCVA was improved 0.5 decimal in high myopia group(95% CI: 0.20-0.70).
According to subgroup analysis in high myopia group, the group of 6D-10D
UCVA was improved 0.63 decimal, the group of over 10D was improved 0.27
decimal. Also, after surface ablation surgery, UCVA change in high myopia
group(over 6D) was 0.83 decimal and in mild myopia group(under 6D) was 0.61
decimal. In addition to UCVA change was decreased over follow up time. However,
after surface ablation surgery manifest refractive change was 7.45 diopter in high
myopia and 4.00 diopter inmildmyopia group. Also, over follow up time, refractive
change was decreased. CONCLUSIONS: This study provides the evidence that
UCVA was decreased according to over time and in high myopia group. Also, Re-
fractive change was fallen down in compliance with over time, but increased in
high myopia group. Our study is the first one to evaluate clinical effectiveness and
stability of LASIK and surface ablation surgery in Korea through systematic review.
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OBJECTIVES: This study quantifies the benefits of surgeon’s volume on outcomes
in lung surgery: lobectomies and wedge resections. The goal of this analysis is to
analyze the effect of technique-specific experience (VATS) on cost, utilization and
adverse events.METHODS:This study utilizes the Premier hospital databasewhich
contains clinical and utilization information on patients receiving care in over 600
US hospitals. Eligible patients were those of any age undergoing lobectomy or
wedge resection using VATS for cancer treatment. Volume measures use addi-
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tional data for patients undergoing lobectomy or wedge resection using open tho-
racotomy. Ourmeasure of volume represents the aggregate experience level of the
surgeon per six month window. Multivariable logistic regression analyses were
estimated for the binary outcome - adverse events. Ordinary Least Squares (OLS)
regression was used for continuous outcomes: hospital costs, surgery time, length
of stay, and number of adverse events. In addition, the following explanatory vari-
ables were included: patient demographics, diagnosis, comorbid conditions, pa-
tient severity index and hospital characteristics. RESULTS: Of 7137 patients in the
database with elective, inpatient resections for lung cancer, a total of 2698 patients
underwent lobectomy (n716) or wedge resection (n1982) using VATS. More than
70% of these procedures were performed by thoracic surgeons (n1896). A positive
volume-outcome relationship appeared as follows: The relationship is stronger for
cost and utilization outcomes versus adverse events, for thoracic surgeons versus
other surgeons, and for VATS lobectomy procedures versus VATS wedge resection
procedures. Finally, we find that while there was a reduction in cost and resource
utilization associatedwith greater experiencewith VATS, these outcomeswere not
strongly linked with greater experience with open procedures. CONCLUSIONS:
There is a reduction in cost and resource utilization associated with greater expe-
riencewithVATS. Greater experiencewith openprocedures does not correlatewith
better VATS outcomes.
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OBJECTIVES: To assess the long-term safety of Laser in situ keratomilieusis (LASIK)
and surface ablation surgery formyopia in South Korea.METHODS:A retrospective
cohort for patients who had a LASIK or surface ablation surgery in 6 hospitals
during 2002-2005 were constructed based on chart reviews and linked to Health
Insurance Review and Assessment (HIRA) claims database during 2005-2009. A
total of 2,422 patients (4,688 eyes) were linked using anonymized identifier after
excluding patients with a history of eye disease, diabetes, hyperopia, or different
surgery methods for both eyes. The frequency of eye disease such as cataract,
glaucoma, retinal detachment, corneal opacity, and keratoconus during 3-8 years
after surgery and the pre-surgery characteristics including age, UCVA (uncorrected
visual acuity), manifest refractive (MR) of patients with eye disease were analyzed.
RESULTS: There were 1,637 LASIK patients and 785 surface ablation patients. The
eye disease after LASIK were cataract (0.2%) and corneal opacity (0.9%) during 3-4
years and cataract (0.1%), glaucoma (0.2%), retinal detachment (0.4%) and corneal
opacity (0.7%) during 4-5 years. The retinal detachment (0.3%) and corneal opacity
(1.3%) were observed during 7-8 years while no keratoconus was identified during
3-8 year follow-up. The pre-surgery MR (meanSD) were 6.981.41 Diopter (D),
7.462.87 D, 6.132.67 D, 6.232.62 D in patients with cataract, glaucoma,
retinal detachment, and corneal opacity, respectively. The incidence of eye disease
after surface ablation was similar to LASIK. CONCLUSIONS: The linkage of clinical
baseline database and nationwide claims database can make up for loss to fol-
low-up in retrospective cohort study. Although it is difficult to explain the causality
of surgery, we could ascertain there was no serious eye disease after surgery.
Surgery – Cost Studies
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ANALYSIS OF FACTORS INFLUENCING INPATIENT MORTALITY AND COSTS
AMONG PEDIATRIC HEART TRANSPLANTATION RECIPIENTS
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OBJECTIVES: To assess the relationship of patient, payer, and hospital character-
istics with cost and mortality in pediatric heart transplant recipients. METHODS:
Data from the 1997, 2000, 2003, and 2006 Agency for Healthcare Research and
Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP) Kids’ Inpatient Da-
tabase (KID) were utilized. Pediatric patients aged 0-17 years receiving heart trans-
plants were included. Logistic regression and generalized linear models were used
for the analyses. Inpatient mortality and inflation-adjusted costs were the out-
comes of interest. Patient demographics and clinical characteristics were the pri-
mary independent variables of interest, with payer and hospital characteristics
used as control variables. Weighting procedures were utilized to yield nationally
representative results. RESULTS: Overall, 1154 patients received heart transplants
during the study timeframe. The average was 6.5 (6.1) years. Mean inpatient
hospital costs were $206,895 (150,504). Inpatient mortality was 7.2%. Children1
year were significantly less likely to die during hospitalization than those 1 year
(p0.05). Hemorrhage (OR4.11, p0.005) and renal failure (OR6.45, p0.001)
were complications associated with mortality. Mortality was also significantly as-
sociated with higher number diagnoses and higher income and inversely related
withWest region andmore recent transplants. Mortality cases incurred 1.68 times
higher costs than those routinely discharged (p0.001). Sepsis (exp(b)1.18,
p0.04), respiratory disease (exp(b)1.08, p0.021), hemorrhage (exp(b)1.22,
p0.001) and renal failure (exp(b)1.15, p0.003) were complications associated
with higher costs. Higher costs were also significantly associated with medium hos-
pital bedsize, age1year, admission fromanother facility, longer lengthsof stay,West
region,more recent transplants andhigher patient income,with lower costs for trans-
plants occurring in a children’s unit of a general hospital. CONCLUSIONS: Multiple
patient and hospital characteristics appear to significantly predict inpatient mor-
tality and costs in pediatric heart transplant recipients.
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OBJECTIVES: Estimate the return of investment (ROI) on bariatric surgery vs. con-
ventional, non-surgical approach as treatment for morbid obesity from the Mexi-
can public health system perspective in the long term. METHODS: The individual
experience of a morbidly-obese patient was assessed using a discrete event simu-
lation model built in Arena™. Patients were created with unique, randomly as-
signed clinical and epidemiologic characteristics, cloned and sent to either bariat-
ric surgery (BS) or conventional treatment – pharmacologic treatment of associated
comorbidities and lifestyle modifications (control arm). Evaluated comorbidities
were type-2 diabetes, hypertension and hypercholesterolemia. Preoperative prev-
alences and up-to year 2 recovery rates were taken from publishedmeta-analyses.
2- and 10-year prevalences were derived from incidence and recovery rates shown
in SOS study; in-between prevalences were interpolated assuming exponential
growth, thus allowing clinical state worsening in both arms. Additional assump-
tions include infrastructure restrictions, no perioperative complications and short
term mortality. 5% of patients in control group were allowed to have surgery after
year 5. Considered costs included the bariatric procedure and comorbidity-specific
pharmacologic treatment, taken from public health institution’s DRGs. Simulation
was run with 150 patients for 10 years and 10 iterations using a 4.5% annual dis-
count rate. Results are shown in years and 2010 inflation-adjusted MXP. 95% con-
fidence intervals were estimated. RESULTS: 10-year accumulated cost for a BS
patient was $125,902 ($125,041-$ 126,763), and $259,413 ($258,098 - $260,728) for a
control patient. ROI on BSwas achieved on year 6.94 (6.88-7.00). Cost differences are
due to the reduced resource utilization after surgery resulting from resolution of
comorbidities. CONCLUSIONS: Investment in BS offsets its cost and is recouped
within a reasonable time, thus allowing institutions to reduce the burden imposed
by morbid obesity. Long-run data for other associated comorbidities is needed, as
their inclusion in the analysis could decrease ROI.
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OBJECTIVES:Treatment guidelines stipulate that clopidogrel should be interrupted
5 days prior to elective coronary artery bypass grafting (CABG) to reduce the risk
of bleeding. However, if urgent CABG is indicated, experienced surgeons may per-
form CABG in 5 days. This study is the first to describe patterns of acute clopi-
dogrel use and inpatient costs among acute coronary syndrome (ACS) patients
undergoing CABG, which will help decision makers understand the relative bene-
fits/costs of antiplatelet therapies in real-world practices. METHODS: The study
used the MarketScan® Commercial, Medicare, and Hospital Drug Databases, com-
prising administrative healthcare data for over 63 million individuals. ACS epi-
sodes, defined as hospitalizations for ACS (primary ICD-9-CM diagnosis 410.xx,
411.1x), occurring between 1/1/2005-6/30/2009 were identified from patients aged
18 years. Outcomes included costs and lengths of stay (LOS) of ACS episodes with
CABG and, among clopidogrel-treated patients, number of days between the day
CABG was performed and the last clopidogrel dose administered. Analyses were
descriptive. RESULTS: 160,168 ACS episodes were identified; mean patient age 
63.5 years. CABG episodes comprised 9.3% (14,896/160,168) of ACS episodes. The
mean LOS was 9.8 [SD 6.8] days per CABG episode. Mean inpatient costs were
$71,140 [SD $68,012] per CABG episode. Among clopidogrel-treated patients with
inpatient drug data who underwent CABG (n8,101), the mean days between the
day CABGwas performed and the last dose of clopidogrel administered was 3.3 [SD
2.6] days and themajority (62.1%) underwent surgerywithin 2-3 days after their last
clopidogrel dose. Themean incremental increase in inpatient costs associatedwith
1 extra LOS day was $1,950. CONCLUSIONS:Data suggest that surgeons commonly
perform CABG within 5 days after clopidogrel administration. However, among
patients for whom urgent CABG is not indicated, withholding CABG may only
minimally affect inpatient costs and must be considered in the broader context of
patient management.
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ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE
UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE
POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND
WALES
Kontekakis A, Gaiser S
Heraeus Medical GmbH, Wehrheim, Germany
OBJECTIVES: The purpose of the study was to quantify the potential effect of the
current trend towardsmore uncemented primary total hip arthroplasties (THAs) in
terms of hospital costs and number of revisions over a 10 year period (2011 to 2021)
in England andWales. In addition the potential impact of changes of this develop-
ment was evaluated.METHODS: Registry data from the National Joint Registry for
England andWales from 2004 to 2009was used to predict the numbers of THAs and
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